指南与共识中枢神经肿瘤放疗姑息放疗与转移瘤

ESTRO-SIOPE指南:非典型畸胎样/横纹肌样肿瘤(AT/RT)放疗的临床管理

ESTRO-SIOPE guideline: Clinical management of radiotherapy in atypical teratoid/rhabdoid tumors (AT/RTs).
指南 / 共识 · Radiother Oncol · 2024-03-14

本指南由ESTRO组建九名欧洲专家委员会,经系统文献检索后提出AT/RT放疗建议,涵盖诊断影像、治疗原则、放疗时机、剂量、技术、靶区定义、危及器官剂量约束、同步化疗及随访,强调应在前瞻性试验或前瞻性登记框架内治疗患儿。

要点

  • 指南为未入组临床试验的AT/RT患儿提供放疗临床管理建议。
  • 建议涵盖放疗时机、剂量、技术、靶区定义及危及器官剂量约束。
  • 强调在前瞻性试验或前瞻性登记框架内治疗AT/RT患儿至关重要。

核心结论

  • 本指南总结了AT/RT患者放疗的证据与基于临床的建议。
  • 在前瞻性试验或前瞻性登记框架内治疗AT/RT患儿至关重要。
  • 评估现代治疗方法的前瞻性临床试验和国际大型登记将有助于未来更好地理解这些患儿的最佳治疗。

研究设计与样本

  • 欧洲放射肿瘤学会(ESTRO)提名九名欧洲专家组成指南委员会。
  • 在PubMed/MEDLINE和Web of Science进行系统文献检索。
  • 委员会讨论并分析放疗在AT/RT临床管理中作用的证据。

主要发现

  • 指南考虑了诊断影像、治疗原则、放疗时机、剂量、技术、靶区定义、放射敏感危及器官的剂量约束、同步化疗及随访等方面的建议。
  • 治疗AT/RT具有挑战性,尤其是年龄低于三岁的非常年幼患儿。
  • 放疗是复杂三联治疗的一部分。

临床怎么用

  • 本指南为未入组临床试验的AT/RT患者提供放疗临床管理建议。
  • 指南建议在前瞻性试验或前瞻性登记框架内治疗AT/RT患儿。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Treatment of patients with atypical teratoid/rhabdoid (AT/RT) is challenging, especially when very young (below the age of three years). Radiotherapy (RT) is part of a complex trimodality therapy. The purpose of this guideline is to provide appropriate recommendations for RT in the clinical management of patients not enrolled in clinical trials. MATERIALS AND METHODS: Nine European experts were nominated to form a European Society for Radiotherapy and Oncology (ESTRO) guideline committee. A systematic literature search was conducted in PubMed/MEDLINE and Web of Science. They discussed and analyzed the evidence concerning the role of RT in the clinical management of AT/RT. RESULTS: Recommendations on diagnostic imaging, therapeutic principles, RT considerations regarding timing, dose, techniques, target volume definitions, dose constraints of radiation-sensitive organs at risk, concomitant chemotherapy, and follow-up were considered. Treating children with AT/RT within the framework of prospective trials or prospective registries is of utmost importance. CONCLUSION: The present guideline summarizes the evidence and clinical-based recommendations for RT in patients with AT/RT. Prospective clinical trials and international, large registries evaluating modern treatment approaches will contribute to a better understanding of the best treatment for these children in future.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Timmermann B, Alapetite C, Dieckmann K, et al. ESTRO-SIOPE guideline: Clinical management of radiotherapy in atypical teratoid/rhabdoid tumors (AT/RTs). Radiother Oncol. 2024. PMID: 38492671. doi:10.1016/j.radonc.2024.110227

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。